Nano- and microparticle-based imaging of cardiovascular interventions: Overview

Radiology

Volumn 243, Issue 2, 2007, Pages 340-347

  Yang, Xiaoming ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; NANOPARTICLE; VASCULOTROPIN;

BIOCOMPATIBILITY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; GENE THERAPY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW;

CARDIOVASCULAR DISEASES; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; IMAGE ENHANCEMENT; MICROSPHERES; NANOPARTICLES;

EID: 34247530750     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2432060307     Document Type: Review

References (51)

1. Thrall JH. Nanotechnology and medicine. Radiology 2004;230:315-318.
2. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005;19:311-330.
3. Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G. Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol 2006;26:435-441.
4. Lipinski MJ, Fuster V, Fisher EA, Fayad ZA. Technology insight: targeting of biological molecules for evaluation of high-risk atherosclerotic plaques with magnetic resonance imaging. Nat Clin Pract Cardiovasc Med 2004;1:48-55.
5. Guccione S, Li KC, Bednarski MD. Vascular-targeted nanoparticles for molecular imaging and therapy. Methods Enzymol 2004;386: 219-236.
6. Blomley MJ, Cooke JC, Unger EC, Monaghan MJ, Cosgrove DO. Microbubble contrast agents: a new era in ultrasound. BMJ 2001;322:1222-1225.
7. Xu L, Pirollo KF, Tang WH, Rait A, Chang EH. Transferrin-liposome- mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 1999;10:2941-2952.
8. Hawker CJ, Wooley KL. The convergence of synthetic organic and polymer chemistries. Science 2005;309:1200-1205.
9. Rubesova E, Berger F, Wendland MP, et al. Gd-labeled liposomes for monitoring liposome-encapsulated chemotherapy: quantification of regional uptake in tumor and effect on drug delivery. Acad Radiol 2002;9(suppl 2):S525-S527.
10. Stinaff EA, Scheibner M, Bracker AS, et al. Optical signatures of coupled quantum dots. Science 2006;311:636-639.
11. Patil S, Pancholi SS, Agrawal S, Agrawal GP. Surface-modified mesoporous ceramics as delivery vehicle for haemoglobin. Drug Deliv 2004;11:193-199.
12. Yang H, Kao WJ. Dendrimers for pharmaceutical and biomedical applications. J Biomater Sci Polym Ed 2006;17:3-19.
13. Radiological Society of North America. Nanoparticles show promise in cancer detection and treatment. RSNA News [newsletter] 2005;15(10):3-5.
14. Hirsch LR, Gobin AM, Lowery AR, et al. Metal nanoshells. Ann Biomed Eng 2006;34: 15-22.
15. Chen HH, Le Visage C, Qiu B, et al. MR imaging of biodegradable polymeric microparticles: a potential method of monitoring local drug delivery. Magn Reson Med 2005; 53:614-620.
16. Le Visage C, Quaglia F, Dreux M, et al. Novel microparticulate system made of poly(methylidene malonate 2.1.2). Biomaterials 2001; 22:2229-2238.
17. Wickline SA, Lanza GM. Nanotechnology for molecular imaging and targeted therapy. Circulation 2003;107:1092-1095.
18. Reimer P, Jahnke N, Fiebich M, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000;217:152-158.
19. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 2004;3: 913-925.
20. Weissleder R, Mahmood U. Molecular imaging. Radiology 2001;219:316-333.
21. Yang X, Atalar E, Li D, et al. Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery. Circulation 2001;104:1588-1590.
22. Du X, Yang Y, Le Visage C, et al. In vivo US monitoring of catheter-based vascular delivery of gene microspheres in pigs: feasibility. Radiology 2003;228:555-559.
23. Kolodgie FD, John M, Khurana C, et al. Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation 2002; 106:1195-1198.
24. Banai S, Chorny M, Gertz SD, et al. Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteries. Biomaterials 2005;26: 451-461.
25. Fayad ZA, Amirbekian V, Toussaint JF, Fuster V. Identification of interleukin-2 for imaging atherosclerotic inflammation. Eur J Nucl Med Mol Imaging 2006;33:111-116.
26. Chen JW, Pham W, Weissleder R, Bogdanov A Jr. Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis. Magn Reson Med 2004;52: 1021-1028.
27. Lanza GM, Wallace KD, Scott MJ, et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. Circulation 1996;94:3334-3340. [Published correction appears in Circulation 1997;95(10): 2458.]
28. Sirol M, Fuster V, Badimon JJ, et al. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005;112:1594-1600.
29. Morawski AM, Winter PM, Crowder KC, et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI. Magn Reson Med 2004;51:480-486.
30. Lanza GM, Trousil RL, Wallace KD, et al. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. J Acoust Soc Am 1998;104: 3665-3672.
31. Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science 2002;296: 2404-2407.
32. Kerr JS, Mousa SA, Slee AM. Alpha(v-)beta(3) integrin in angiogenesis and restenosis. Drug News Perspect 2001;14:143-150.
33. Winter PM, Morawski AM, Caruthers SD, et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003;108:2270-2274.
34. Nabel E, Leiden J. Gene transfer approaches for cardiovascular disease. In: Chien K, ed. Molecular basis of cardiovascular disease. Philadelphia, Pa: Saunders, 1999; 86-112.
35. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000;355:213-222.
36. Newman CM, Lawrie A, Brisken AF, Cumberland DC. Ultrasound gene therapy: on the road from concept to reality. Echocardiography 2001;18:339-347.
37. Unger EC, Hersh E, Vannan M, Matsunaga TO, McCreery T. Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 2001;44:45-54.
38. Guzman HR, Nguyen DX, Khan S, Prausnitz MR. Ultrasound-mediated disruption of cell membranes. II. Heterogeneous effects on cells. J Acoust Soc Am 2001;110:597-606.
39. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995;269:850-853.
40. Lawrie A, Brisken AF, Francis SE, et al. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation 1999;99:2617-2620.
41. Amabile PG, Waugh JM, Lewis TN, Elkins CJ, Janas W, Dake MD. High-efficiency endovascular gene delivery via therapeutic ultrasound. J Am Coll Cardiol 2001;37:1975-1980.
42. Shohet RV, Chen S, Zhou YT, et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000;101:2554-2556.
43. Akowuah EF, Gray C, Lawrie A, et al. Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Ther 2005;12:1154-1157.
44. Anwer K, Kao G, Proctor B, et al. Ultrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration. Gene Titer 2000;7:1833-1839.
45. Klibanov AL. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 1999;37: 139-157.
46. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001;220:640-646.
47. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998;98:290-293.
48. Tiukinhoy SD, Mahowald ME, Shively VP, et al. Development, of echogenic, plasmid-incorporated, tissue-targeted cationic liposomes that can be used for directed gene delivery. Invest. Radiol 2000;35:732-738.
49. Lanza GM, Yu X, Winter PM, et al. Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation 2002;106:2842-2847.
50. Yu X, Zhan X, D'Costa J, et al. Lentiviral vector with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther 2003;7:827-838.
51. Gao F, Qiu B, Kar S, Zhan X, Hofmann LV, Yang X. Intravascular magnetic resonance/ radiofrequency may enhance gene therapy for prevention of irr-stent neointimal hyperplasia. Acad Radiol 2006;13:526-530.